Table 1.

Baseline information of literature included.

References	Country	Research type	Endpoint criteria	N
Tan et al. (10)	China	Cohort study	OR value of poor mRS Score in 3 months	204
Zhang et al. (11)	China	Cohort study	OR value of poor mRS Score in 3 months; OR value for cerebral infarction mortality	351
Zhai et al. (12)	China	Cohort study	OR value of poor mRS Score in 3 months; OR value for cerebral infarction mortality; RR value for morbidity of hypertension, diabetes, CHD, cerebral infarction, hyperlipemia	225
Rexidamu et al. (13)	China	Cohort study	OR value of poor mRS Score in 3 months; OR value for NIHSS>5	255
Chen et al. (14)	China	Case–control study	OR value of poor mRS Score in 3 months; OR value for morbidity of cerebral infarction; RR value for morbidity of hypertension, diabetes	291
Schneider et al. (15)	Germany	Case–control study	OR value of poor mRS Score in 3 months	296
Xu et al. (16)	China	Registry-based study	HR value of cerebral infarction recurrence; RR value for morbidity of hypertension, diabetes, CHD, cerebral infarction, hyperlipemia	10,027
Sun et al. (17)	China	Case–control study	OR value of morbidity of cerebral infarction	1906
Liu et al. (18)	China	Nested case–control studies	OR value of morbidity of cerebral infarction	642
Chen et al. (19)	China	Case–control study	OR value of morbidity of cerebral infarction	610
Xue et al. (20)	China	Registry-based study	HR value of cerebral infarction recurrence; RR value for morbidity of hypertension, CHD, cerebral infarction	9,793
Heyse et al. (21)	Germany	Case–control study	OR value of morbidity of cerebral infarction	82
Xu et al. (22)	China	Registry-based study	HR value of cerebral infarction recurrence	10,756
Xu et al. (23)	China	Registry-based study	HR value of cerebral infarction recurrence; RR value for morbidity of hypertension, diabetes, CHD, cerebral infarction, hyperlipemia	4,186
Wu et al. (24)	China	Case–control study	OR value for NIHSS>5	427